Geoffrey Appelboom Selected Research

Diabetes Mellitus

7/2011

Severity of intraventricular extension correlates with level of admission glucose after intracerebral hemorrhage.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Geoffrey Appelboom Research Topics

Disease

7	Cerebral Hemorrhage 08/2013 - 01/2011
3	Neoplasms (Cancer) 09/2019 - 06/2015
3	Aneurysm (Aneurysms) 01/2013 - 03/2010
3	Ischemic Stroke 06/2011 - 12/2010
2	Infections 09/2016 - 01/2016
2	Hematoma 08/2013 - 01/2011
2	Intracranial Aneurysm (Cerebral Aneurysm) 01/2013 - 03/2010
2	Inflammation (Inflammations) 10/2012 - 01/2011
2	Hemorrhage 04/2012 - 01/2012
2	Edema (Dropsy) 01/2012 - 01/2011
2	Hyperglycemia 07/2011 - 06/2011
1	Cerebrospinal Fluid Rhinorrhea 01/2022
1	Pituitary Neoplasms (Pituitary Adenoma) 01/2022
1	Glioma (Gliomas) 09/2019
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2019
1	Venous Thrombosis (Deep-Vein Thrombosis) 05/2016
1	Pulmonary Embolism 05/2016
1	Leukopenia 01/2016
1	Surgical Wound Infection 01/2016
1	Brain Neoplasms (Brain Tumor) 06/2015
1	Traumatic Brain Injuries (Traumatic Brain Injury) 11/2013
1	Brain Injuries (Brain Injury) 10/2012
1	Glioblastoma (Glioblastoma Multiforme) 04/2012
1	Hyperemia 01/2012
1	Arteriovenous Malformations (Arteriovenous Malformation) 01/2012
1	Wounds and Injuries (Trauma) 11/2011
1	Intracranial Arteriovenous Malformations (Cerebral Arteriovenous Malformation) 09/2011
1	Diabetes Mellitus 07/2011
1	Thrombosis (Thrombus) 06/2011
1	Stroke (Strokes) 06/2011
1	Hemorrhagic Stroke 01/2011
1	Ischemia 01/2011
1	Critical Illness (Critically Ill) 12/2010

Drug/Important Bio-Agent (IBA)

2	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2016 - 01/2016
2	Biomarkers (Surrogate Marker)IBA 10/2012 - 04/2012
2	Glucose (Dextrose)FDA LinkGeneric 07/2011 - 06/2011
2	Neuroprotective AgentsIBA 01/2011 - 01/2011
1	CollagenIBA 01/2022
1	TachoSilIBA 01/2022
1	FibrinIBA 01/2022
1	AGuIXIBA 09/2019
1	GadoliniumIBA 09/2019
1	SteroidsIBA 05/2016
1	Hemostatics (Antihemorrhagics)IBA 08/2013
1	von Willebrand FactorIBA 08/2013
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2013
1	macromolecular insoluble cold globulinIBA 01/2013
1	Blood Proteins (Serum Proteins)IBA 10/2012
1	AnticoagulantsIBA 04/2012
1	5-nitro-2-(3-phenylpropylamino)benzoic acidIBA 01/2012
1	Complement Factor H (Factor H)IBA 11/2011
1	Complement C3a (Complement 3a)IBA 09/2011
1	Complement System Proteins (Complement)IBA 09/2011
1	Dihydrotachysterol (AT 10)IBA 07/2011
1	Anesthetics (Anesthetic Agents)IBA 01/2011
1	Isoflurane FDA LinkGeneric 01/2011
1	Silk FDA Link 03/2010

Therapy/Procedure

6	Therapeutics 12/2012 - 12/2010
2	Drug Therapy (Chemotherapy) 01/2016 - 06/2015
1	Precision Medicine 09/2019
1	Deep Brain Stimulation 01/2019
1	Patient Readmission 09/2016
1	Cerebrospinal Fluid Shunts 09/2016
1	Radiotherapy 06/2015
1	Neoadjuvant Therapy 06/2015
1	Decompressive Craniectomy 11/2013
1	Surgical Instruments (Clip) 01/2013
1	Endoscopes 01/2013
1	Aftercare (After-Treatment) 01/2012
1	Time-to-Treatment 06/2011
1	Patient Admission (Patient Admissions) 06/2011
1	Catheters 12/2010
1	Stents 03/2010